Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2014-03-06 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: DECINES-CHARPIEU (69150), Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE MONTABERLET : revenue, balance sheet and financial ratios
PHARMACIE DE MONTABERLET is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in DECINES-CHARPIEU (69150),
this company of category PME
shows in 2022 a revenue of 826 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE MONTABERLET (SIREN 800839607)
Indicator
2024
2023
2022
2022
2021
2020
2019
Revenue
N/C
N/C
825 798 €
N/C
N/C
N/C
N/C
Net income
1 655 €
36 302 €
11 578 €
163 222 €
188 443 €
126 229 €
180 943 €
EBITDA
N/C
N/C
21 133 €
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
1.4%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE MONTABERLET generates positive net income of 2 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 181 k€ -> 2 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
1 655 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 34%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
33.632%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
66.095%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE MONTABERLET
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2022
2023
2024
Debt ratio
88.702
64.342
47.957
35.443
30.875
32.842
33.632
Financial autonomy
49.793
57.371
62.707
67.064
70.359
64.021
66.095
Repayment capacity
None
None
None
None
27.917
None
None
Cash flow / Revenue
None%
None%
None%
None%
1.795%
None%
None%
Sector positioning
Debt ratio
33.632024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good+7 pts over 3 years
In 2024, the debt ratio of PHARMACIE DE MONTABERLET (33.63) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
66.09%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good
In 2024, the financial autonomy of PHARMACIE DE MONTABERLET (66.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
27.92 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Watch
In 2022, the repayment capacity of PHARMACIE DE MONTABERLET (27.92) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 103.22. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
103.225
Liquidity indicators evolution PHARMACIE DE MONTABERLET
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2022
2023
2024
Liquidity ratio
553.849
558.252
512.005
444.446
441.0
112.003
103.225
Interest coverage
None
None
None
None
15.365
None
None
Sector positioning
Liquidity ratio
103.222024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Watch-54 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE MONTABERLET (103.22) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
15.37x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of PHARMACIE DE MONTABERLET (15.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE MONTABERLET
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
191 750 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
29
0
0
Customer payment term (days)
0
0
0
0
23
0
0
Supplier payment term (days)
0
0
0
0
61
0
0
Positioning of PHARMACIE DE MONTABERLET in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE MONTABERLET is estimated at
23 105 €
(range 16 089€ - 34 566€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
16k€23k€34k€
23 105 €Range: 16 089€ - 34 566€
NAF 5 année 2024
Valuation method used
Net Income Multiple
1 655 €
×
14.0x
=23 105 €
Range: 16 090€ - 34 566€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE MONTABERLET with other companies in the same sector:
Frequently asked questions about PHARMACIE DE MONTABERLET
What is the revenue of PHARMACIE DE MONTABERLET ?
The revenue of PHARMACIE DE MONTABERLET in 2022 is 826 k€.
Is PHARMACIE DE MONTABERLET profitable?
Yes, PHARMACIE DE MONTABERLET generated a net profit of 2 k€ in 2024.
Where is the headquarters of PHARMACIE DE MONTABERLET ?
The headquarters of PHARMACIE DE MONTABERLET is located in DECINES-CHARPIEU (69150), in the department Rhone.
Where to find the tax return of PHARMACIE DE MONTABERLET ?
The tax return of PHARMACIE DE MONTABERLET is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE MONTABERLET operate?
PHARMACIE DE MONTABERLET operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart